Pharmalot… Pharmalittle… Good Morning
Make a commentBy Ed Silverman // June 24th, 2010 // 6:47 am
A balmy day here on the Pharmalot corporate campus, where the short people are now sleeping in and dreaming of summer activities. We, however, are digging in for the usual routine of meetings and deadlines. What about you? Does a busy day lie ahead? For those seeking an advantage or a diversion, here are some items to help you along. Have a great day, everyone, and stay in touch…
Merck Strikes OTC Deal With Adcock-Ingram (Bloomberg)
A New Way To Detect Alzheimer’s (The New York Times)
FDA Approves Merck Lung Drug (Reuters)
EMA Approves New Use For Glaxo’s Tyverb (PharmaTimes)
Crucell Starts Work On RSV Vaccine (Reuters)
UK’s NICE Rejects Glaxo Leukemia Drug (Reuters)
Patent Awarded For New Drug Delivery System To Aphios (InPharmaTechnologist)
Leave a Comment
Subscribe
Comments feed for this post only.
Tags
Adcock-Ingram, Aphios, Crucell, GlaxoSmithKline, Leukemia, Merck, NICE, OTC, Over The Counter, RSV, RSV Vaccine, South Africa, Tyberg, Vaccines